MEHJABEIN Y KHAN
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology KENOSHA, WI NPI 1477500312
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology WI ABBVIE INC. All categories
General Payments — all program years on this page
$1,977.13
- Category: General Payments
- Program years: PY2022–2024
- Record count: 99
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $922.50 across 45 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $922.50 | 45 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $172.51 | 9 |
| Amgen Inc. | $135.72 | 7 |
| Acerta Pharma LLC | $90.94 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $73.80 | 3 |
| ANI Pharmaceuticals, Inc. | $59.96 | 2 |
| GlaxoSmithKline, LLC. | $50.45 | 3 |
| Biocon Biologics Inc | $48.28 | 2 |
| PFIZER INC. | $47.56 | 2 |
| UCB, Inc. | $32.68 | 2 |
| Lilly USA, LLC | $31.21 | 2 |
| GENZYME CORPORATION | $26.22 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.98 | 1 |
| Alexion Pharmaceuticals, Inc. | $23.43 | 1 |
| Aurinia Pharma U.S., Inc. | $21.68 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.24 | 1 |
| Genentech USA, Inc. | $19.19 | 1 |
| Sandoz Inc. | $17.97 | 1 |
| Janssen Biotech, Inc. | $13.89 | 1 |
| Ultragenyx Pharmaceutical Inc. | $13.79 | 1 |
By program year
Records — PY2024 (45)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.